Asset 1

Gentest® Megakaryocyte Maturation and Platelet Development Assay Services

Assess thrombocytopenia potential caused by drug candidate toxicity to megakaryocytes and platelets at various stages of development.

While Megakaryocytic colony forming cell (CFC) assays are predictive of thrombocytopenia caused by drugs impacting the primitive progenitor stage, toxicity can also occur at later stages of cell development.

Discovery’s megakaryocyte maturation and platelet development assay services assess the off-target toxicity potential of your drug candidate on developing megakaryocytes and megakaryocyte-derived platelets at different stages of cell development.

Contact Us Today

Quick Links


Development and Clinical
Trial Solutions